Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes - Melanie J. Davies; Harpreet S. Bajaj; Christa Broholm; Astrid Eliasen; W. Timothy Garvey; Carel W. le Roux; Ildiko Lingvay; Christian Bøge Lyndgaard; Julio Rosenstock; Sue D. Pedersen (New England Journal of Medicine, 2025)